# UF Reproductive Medicine at Springhill – FDA Inspection, Jun 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/uf-reproductive-medicine-at-springhill/d64d15f4-c982-4613-9255-a2bd0e9c4f22
Source feed: FDA_Inspections

> FDA inspection 1092804 of UF Reproductive Medicine at Springhill, June 06, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 1271. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1092804
- Company Name: UF Reproductive Medicine at Springhill
- Inspection Date: 2019-06-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1303158 - 2026-02-09
- FDA Inspection 1191870 - 2022-11-07
- FDA Inspection 987875 - 2016-09-27
- FDA Inspection 895060 - 2014-09-11
- [FDA Inspection 735060 - 2011-07-18](https://www.keypedia.com/records/fda_inspections/uf-reproductive-medicine-at-springhill/392d1f26-762e-4288-98fb-4dfedbd3a667)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/uf-reproductive-medicine-at-springhill/c5a462e7-cc93-4ddc-a8a8-b0ef73ca28e0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
